Please assess the completion status of the following clinical trial:

Trial Title: Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 7.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects must have documented rheumatoid arthritis with a duration of at least 3 months as determined by the investigator using standardly accepted criteria, must have been receiving methotrexate for at least 3 months to treat their rheumatoid arthritis, and must be free of any signs or symptoms of infection.~Exclusion Criteria:~* Subjects cannot enter the study if they have recently received treatment with certain medications which might interfere with study medications;~* subjects cannot enter if they have abnormalities in certain blood tests, history of cancer, recent bone fracture or other significant conditions.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PF-04171327 1 mg QD (Type: EXPERIMENTAL): None
- PF-04171327 5 mg QD (Type: EXPERIMENTAL): None
- PF-04171327 10 mg QD (Type: EXPERIMENTAL): None
- PF-04171327 15 mg QD (Type: EXPERIMENTAL): None
- prednisone 5 mg QD (Type: ACTIVE_COMPARATOR): None
- prednisone 10 mg QD (Type: ACTIVE_COMPARATOR): None
- placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).